The FDA on Wednesday approved the industry’s first-ever tablet treatment for spinal muscular atrophy— Roche ’s SMN2 splicing ...

Over the past nine years, patients with spinal muscular atrophy have seen the number of FDA-approved treatment options for ...

In an interview with pharmaphorum, Marius Scholtz, country medical lead for Roche UK, said the drug will have around the same yearly cost in relapsing disease as Novartis’ once-daily pill ...

Going beyond the pill is proving to be a win/win for patients ... which was supported by Roche Diabetes Care, and delivered by accredited therapists who had been trained to understand and manage ...

We think its portfolio and pipeline support a wide moat, and with the HCV market stabilizing, Gilead needs strong continued innovation in HIV, solid oncology pipeline data, and smart future ...

Viking Therapeutics is a clinical-stage biotech company focused on developing weight-loss therapies. Read why I rate VKTX ...

At this time, I'd like to welcome everyone to the Biogen fourth-quarter and full-year 2024 earnings call and business update. [Operator instructions] Today's conference is being recorded. Thank you. I ...

Drugmakers raised the list prices of more than 800 prescription drugs for blood pressure, cancer and other conditions by a median 4% at the start of this year. The modest size of the annual increases ...

After Roche’s hard-fought first-line approval for ... there are a lot of patients who would rather be treated with the pills than with an injection,” Hoppenot noted, pointing to how Amgen ...

As tame a league opening as they come for Cork but this trip to Chadwicks Wexford Park was a useful exercise for Pat Ryan. A ...

PTC Therapeutics has a drug, now called votoplam, taken as a pill to lower production of huntingtin in the ... Ed Wild is a consultant for uniQure, Roche, PTC Therapeutics and several other companies ...